Movetis

Movetis was a pharmaceutical company headquartered in Belgium. It was founded in 2006 as a spin-off from parent company Johnson & Johnson. The company specialized in pharmaceuticals for treating gastro-intestinal disorders. It was acquired by Shire in 2010.

Movetis

Company type	Public company
Founded	2006 (2006)
Founders	Staf Van Reet, Remi Van den Broeck, Dirk Reyn, Jan Schuurkes, and Johnson & Johnson
Defunct	2010 (2010)
Fate	Acquired
Successor	Shire (pharmaceutical company)
Headquarters	Belgium
Area served	Worldwide
Key people	Staf Van Reet (CEO)
Products	Gastro-intestinal drugs
Website	www.movetis.com at the Wayback Machine (archived January 7, 2010)

The primary drug produced by Movetis was Prucalopride (known by the brand name "Resolor"), indicated for cases of chronic constipation.

History

Movetis was founded by Dirk Reyn, Staf Van Reet, Jan schuurkes and Remi VandenBroek, and was backed by venture firms Sofinnova Partners, Sofinnova Ventures and Life Sciences Partners. In December 2009, it became a public company with an IPO on the New York Stock Exchange's Euronext.^[1] Shortly thereafter, it gained regulatory approval to distribute Resolor in 30 European countries.

In 2010, the company was acquired by British drugmaker Shire Plc for 428 million euros ($559 million).^[2]